Zobrazeno 1 - 10
of 197
pro vyhledávání: '"Pilar, García Alfonso"'
Autor:
Khalid A. Alnaqbi, Agnès Bellanger, Alex Brill, Gilberto Castañeda-Hernández, Ana Clopés Estela, Olga Delgado Sánchez, Pilar García-Alfonso, Pius Gyger, Daniel Heinrich, Germain Hezard, Adriana Kakehasi, Cheryl Koehn, Olivier Mariotte, Francesco Mennini, Sonia Mayra Pérez-Tapia, Michele Pistollato, Rowan Saada, Tadanori Sasaki, George Tambassis, Marc Thill, Gustavo Werutsky, Tim Wilsdon, Steven Simoens
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: Although biosimilar uptake has increased (at a variable pace) in many countries, there have been recent concerns about the long-term sustainability of biosimilar markets. The aim of this manuscript is to assess the sustainability of polic
Externí odkaz:
https://doaj.org/article/21e2850e32424b76ad1f5aed8e8e32e0
Publikováno v:
Cirugía y Cirujanos, Vol 90, Iss 3 (2022)
Objective: This study aims to investigate the relationship between the pre-operative indocyanine green (ICG) test, the chemotherapy- associated liver injury (CALI), and the development of severe post-operative complications (POC) in patients operated
Externí odkaz:
https://doaj.org/article/92e6061bdc614cc6b7b29b87c47b50e3
Autor:
Lucía Trilla-Fuertes, Angelo Gámez-Pozo, Joan Maurel, Rocio Garcia-Carbonero, Jaume Capdevila, Laura G-Pastrián, Marta Mendiola, Cristina Peña, Rocío López-Vacas, Miriam Cuatrecasas, Pilar García-Alfonso, Ricardo Ramos-Ruiz, Carlos Llorens, Ismael Ghanem, Carles Conill, Victoria Heredia-Soto, Ángel Campos-Barros, Juan Ángel Fresno Vara, Jaime Feliu
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract Squamous cell carcinoma is the most frequent histologic type of anal carcinoma. The standard of care since the 1970s has been a combination of 5-fluorouracil, mitomycin C, and radiotherapy. This treatment is very effective in T1/T2 tumors (a
Externí odkaz:
https://doaj.org/article/d4fe26f9fdff4908953ce34c605cf410
Autor:
Pilar García-Alfonso, Andrés Jesús Muñoz Martín, Laura Ortega Morán, Javier Soto Alsar, Gabriela Torres Pérez-Solero, Montserrat Blanco Codesido, Pilar Aitana Calvo Ferrandiz, Silvina Grasso Cicala
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Colorectal cancer (CRC) is one of the most common forms of cancer, with an estimated 1.36 million new cases and almost 700,000 deaths annually. Approximately 21% of patients with CRC have metastatic disease at diagnosis. The objective of this article
Externí odkaz:
https://doaj.org/article/344cd31c70874b66a91affaa308d000e
Autor:
Ruth Vera, Carolina Ibarrola-de-Andrés, Jorge Adeva, Judith Pérez-Rojas, Pilar García-Alfonso, Yolanda Rodríguez-Gil, Teresa Macarulla, Teresa Serrano-Piñol, Rebeca Mondéjar, Beatriz Madrigal-Rubiales
Publikováno v:
CLINICAL & TRANSLATIONAL ONCOLOGY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Scientia
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Scientia
Biliary tract cancer; Predictive value; Targeted therapies Cáncer de vías biliares; Valor predictivo; Terapias dirigidas Càncer de vies biliars; Valor predictiu; Teràpies dirigides Pancreatic cancer and biliary tract cancer have a poor prognosis.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::776355713a37a78f72c939c9bad1feab
https://doi.org/10.1016/j.patol.2022.06.004
https://doi.org/10.1016/j.patol.2022.06.004
Comprehensive Characterization of the Mutational Landscape in Localized Anal Squamous Cell Carcinoma
Autor:
Lucía Trilla-Fuertes, Ismael Ghanem, Joan Maurel, Laura G-Pastrián, Marta Mendiola, Cristina Peña, Rocío López-Vacas, Guillermo Prado-Vázquez, Elena López-Camacho, Andrea Zapater-Moros, Victoria Heredia, Miriam Cuatrecasas, Pilar García-Alfonso, Jaume Capdevila, Carles Conill, Rocío García-Carbonero, Karen E. Heath, Ricardo Ramos-Ruiz, Carlos Llorens, Ángel Campos-Barros, Angelo Gámez-Pozo, Jaime Feliu, Juan Ángel Fresno Vara
Publikováno v:
Translational Oncology, Vol 13, Iss 7, Pp 100778- (2020)
Anal squamous cell carcinoma (ASCC) is a rare neoplasm. Chemoradiotherapy is the standard of care, with no therapeutic advances achieved over the past three decades. Thus, a deeper molecular characterization of this disease is still necessary. We ana
Externí odkaz:
https://doaj.org/article/63d83246fc3d4f4a8991a5fc8d8faaad
Autor:
David Fogelman, Antonio Cubillo, Pilar García‐Alfonso, María Luisa Limón Mirón, John Nemunaitis, Daniel Flora, Christophe Borg, Laurent Mineur, Jose M. Vieitez, Allen Cohn, Gene Saylors, Albert Assad, Julie Switzky, Li Zhou, Johanna Bendell
Publikováno v:
Cancer Medicine, Vol 7, Iss 11, Pp 5382-5393 (2018)
Abstract Background The Janus kinase/signal transducer and activator of transcription (JAK‐STAT) signaling pathway plays a key role in the systemic inflammatory response in many cancers, including colorectal cancer (CRC). This study evaluated the a
Externí odkaz:
https://doaj.org/article/83944eb504bf49ddba72860007a550e7
Autor:
J. Han van Krieken, George Kafatos, James Bennett, Laurent Mineur, Jiří Tomášek, Etienne Rouleau, Pavel Fabian, Giovanna De Maglio, Pilar García-Alfonso, Giuseppe Aprile, Parijan Parkar, Gerald Downey, Gaston Demonty, Jörg Trojan
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-9 (2017)
Abstract Background In Europe, treatment of metastatic colorectal cancer (mCRC) with panitumumab requires prior confirmation of RAS wild-type mutation status. Two studies – a physician survey and a medical records review (MRR) – were conducted to
Externí odkaz:
https://doaj.org/article/18d47edf49e44600a880412a7960bfe2
Autor:
Ana Fernández Montes, Vicente Alonso, Enrique Aranda, Elena Élez, Pilar García Alfonso, Cristina Grávalos, Joan Maurel, Ruth Vera, Rosario Vidal, Jorge Aparicio
Publikováno v:
Clinical and Translational Oncology.
Colorectal cancer (CRC) is the second leading cause of cancer deaths in Spain. Metastatic disease is present in 15–30% of patients at diagnosis and up to 20–50% of those with initially localized disease eventually develop metastases. Recent scien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fece7cbdb0f49ae011f7ca6249dd4952
https://doi.org/10.1007/s12094-023-03199-1
https://doi.org/10.1007/s12094-023-03199-1
Autor:
Clara Montagut, Ramon Salazar, Enrique Aranda, Josep Tabernero, Beatriz Bellosillo, Fernando Rivera, Javier Sastre, Estela Pineda, Ferran Losa, Reyes Ferreiro, Rocío Garcia-Carbonero, José Luís Manzano, Elena Elez, Gema Durán, Cristina Santos, Maria Teresa Cano, Vicente Alonso, Marta Guix, David Páez, Pilar García-Alfonso, David Casadevall, Maria Concepción Fernández-Rodríguez, Joana Vidal
Purpose:Chemotherapy plus anti-EGFR is standard first-line therapy in RAS wild-type (wt) metastatic colorectal cancer (mCRC), but biomarkers of early response are clinically needed. We aimed to define the utility of ctDNA to assess early response in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ed11c20d1556270e0bfe4b1c0086745
https://doi.org/10.1158/1078-0432.c.6532748.v1
https://doi.org/10.1158/1078-0432.c.6532748.v1
